Choline alfoscerate in the correction of cognitive impairment
In preclinical and clinical studies, choline alfoscerate (CA) has proven to be highly effective in the correction of cognitive impairment (CI). The clinical effect of CA is seen in the improvement of mental activity, concentration, ability to remember and recall information, cognitive and behavioura...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
IMA-PRESS LLC
2023-12-01
|
| Edice: | Неврология, нейропсихиатрия, психосоматика |
| Témata: | |
| On-line přístup: | https://nnp.ima-press.net/nnp/article/view/2149 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|